Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-30"MaximALL" More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)
-
CLINICAL_TRIALS study record update · 2026-10-30Phase II Haploidentical Hematopoietic Stem Cell Transplantation for Participants With Germline RUNX1 Associated Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-10-30Mosaic: RCT of a Digital Health Intervention for English- and Spanish-speaking Stem Cell Transplant Recipients
-
CLINICAL_TRIALS study record update · 2026-10-30Pilot Phase I Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
-
CLINICAL_TRIALS study record update · 2026-10-29A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-10-29A Phase II Study of the Non-Covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab in Patients With Marginal Zone Lymphoma
-
CLINICAL_TRIALS study record update · 2026-10-29Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
-
CLINICAL_TRIALS study record update · 2026-10-29REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
-
CLINICAL_TRIALS study record update · 2026-10-29Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
-
CLINICAL_TRIALS study record update · 2026-10-28Tissue Procurement For Hematolymphoid Conditions
-
CLINICAL_TRIALS study record update · 2026-10-28Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 1/2 Clinical Study Evaluating MDX2003 in Participants With Relapsed, Progressive, or Refractory B-Cell Malignancies
-
CLINICAL_TRIALS study record update · 2026-10-28A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-10-27A Multicenter, Open-label, Interventional Phase I Trial to Determine the Dose and Evaluate the Pharmacokinetics (PK) and Safety of Lutetium Lu 177 Edotreotide Targeted Radiopharmaceutical Therapy (RPT) as Monotherapy or Following Standard of Care (SoC) for the Treatment of Somatostatin Receptor-positive Tumors in the Pediatric Population (KinLET).
-
CLINICAL_TRIALS study record update · 2026-10-27Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy: A First in Human Randomized Pilot Study. Neuromodulation in Cancer Study (OU-SCC-NCAN)
-
CLINICAL_TRIALS study record update · 2026-10-26Molecular Analysis for Therapy Choice (MATCH)
-
CLINICAL_TRIALS study results posted · 2026-10-06Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-10-06Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study results posted · 2026-09-16Phase I/IIA Study of the Novel Antifolate Agent Pralatrexate in Combination With the Histone Deacetylase Inhibitor Romidepsin for the Treatment of Patients With Peripheral T-cell Lymphoma
-
CLINICAL_TRIALS study results posted · 2026-09-10Do Decreased Dietary Fat and Increased Fiber Reduce Recurrence of Clostridioides Difficile Infection in Oncology Patients?
-
CLINICAL_TRIALS study results posted · 2026-06-15A Randomized, Open Label Pilot Trial of a Biomarker Guided Strategy of Cardioprotection in Patients With Lymphoma or Breast Cancer Treated With Anthracyclines
-
CLINICAL_TRIALS study record update · 2026-04-27A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-04-27Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
-
CLINICAL_TRIALS study record update · 2026-04-27Phase II Haploidentical Hematopoietic Stem Cell Transplantation for Participants With Germline RUNX1 Associated Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-27Investigation of the Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy